PHARMACY

Gilead’s Trodelvy receives FDA nod for new indication
Trodelvy is now approved for pre-treated HR+/HER2- metastatic breast cancer.
Cardinal Health report examines shifts in biosimilars industry
The study reveals provider perceptions of commercially available biosimilars and anticipated launches, which have the potential to increase equitable access to critical treatments.

AAM’s Biosimilars Council responds to adalimumab biosimilars report

The new report from Matrix Global Advisors illustrates the complexities of the burgeoning adalimumab biosimilar market, the Biosimilars Council said.
Amgen, AstraZeneca obtain FDA nod for Tezspire self-administration

Tezspire is now approved for self-administration in a pre-filled, single-use pen for patients aged 12 years old and older with severe asthma.
Accord Healthcare offers generic Latuda

Lurasidone, an oral atypical antipsychotic, is a first-line treatment option for the management of schizophrenia in adults and adolescents.
Amazon completes $3.9B deal to acquire One Medical

One Medical offers in-office and 24/7 virtual care services, on-site labs and programs for preventive care, chronic care management, common illnesses and mental health concerns.
AAM names 2023 board of directors

Christine Baeder, senior vice president and chief operating officer for U.S. generics, Teva Pharmaceuticals USA is the 2023 AAM chair of the board.
Watch DSN: Walgreens pharmacists on the frontlines of patient testing services

Drug Store News interviewed Anita Patel, vice president of pharmacy services development at Walgreens, about how the retailer is utilizing pharmacists in patient care and testing.
Alembic launches generic Latuda

Generic Latuda is used to treat a depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients as monotherapy.
Amgen intros Humira biosimilar

Amgen's Amjevita is the first U.S. biosimilar to AbbVie's Humira.